No summary has been written for this.
First Trust Nasdaq Pharmaceuticals ETF is an exchange-traded fund that provides focused exposure to the U.S. pharmaceutical industry. The fund seeks to track the Nasdaq U.S. Smart Pharmaceuticals Index, which selects liquid pharmaceutical companies and weights them using factors such as value, volatility, and growth. Its portfolio is built around well-known healthcare and drugmakers, giving investors access to a diversified group of companies involved in prescription medicines, biotechnology-adjacent development, and related healthcare services. First Trust Nasdaq Pharmaceuticals ETF is used as a sector-specific investment tool for market participants looking to follow the performance of the pharmaceuticals segment rather than the broader healthcare market. By concentrating on pharmaceutical businesses, the fund plays a role in helping investors gain targeted access to one of the most important areas of the healthcare economy.
The latest articles about FTXH.
Smart Beta ETF report for FTXN
No summary yet.
No summary yet.
No summary yet.
No summary yet.
No summary yet.
Investors talking about FTXH also mention these. Each card shows that asset’s own numbers for the past 24 hours.